Nabarro advises Numis on £25.5m placing to raise additional capital for Retroscreen

Nabarro is advising existing client Numis Securities on a £25.5m placing to raise additional capital for AIM-traded Retroscreen Virology.

Retroscreen conducts research into antiviral drugs and vaccines through the use of its ‘Viral Challenge Model’, which involves infecting healthy human volunteers with a virus under controlled conditions.

The Nabarro team advising Numis in its capacity as nomad and broker for Retroscreen was led by corporate partner Alasdair Steele, assisted by senior associate Jack Shepherd and trainee Nikita Arora.